Literature DB >> 27509068

Cellular Delivery of RNA Nanoparticles.

Lorena Parlea1, Anu Puri1, Wojciech Kasprzak2, Eckart Bindewald2, Paul Zakrevsky1, Emily Satterwhite3, Kenya Joseph3, Kirill A Afonin3,4,5, Bruce A Shapiro1.   

Abstract

RNA nanostructures can be programmed to exhibit defined sizes, shapes and stoichiometries from naturally occurring or de novo designed RNA motifs. These constructs can be used as scaffolds to attach functional moieties, such as ligand binding motifs or gene expression regulators, for nanobiology applications. This review is focused on four areas of importance to RNA nanotechnology: the types of RNAs of particular interest for nanobiology, the assembly of RNA nanoconstructs, the challenges of cellular delivery of RNAs in vivo, and the delivery carriers that aid in the matter. The available strategies for the design of nucleic acid nanostructures, as well as for formulation of their carriers, make RNA nanotechnology an important tool in both basic research and applied biomedical science.

Entities:  

Keywords:  RNA; RNA nanoparticle; delivery; nanoconstruct; self-assembly; therapeutics

Mesh:

Substances:

Year:  2016        PMID: 27509068      PMCID: PMC6345529          DOI: 10.1021/acscombsci.6b00073

Source DB:  PubMed          Journal:  ACS Comb Sci        ISSN: 2156-8944            Impact factor:   3.784


  239 in total

1.  TectoRNA: modular assembly units for the construction of RNA nano-objects.

Authors:  L Jaeger; E Westhof; N B Leontis
Journal:  Nucleic Acids Res       Date:  2001-01-15       Impact factor: 16.971

Review 2.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

Authors:  C A Lipinski; F Lombardo; B W Dominy; P J Feeney
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

3.  Structural diversity of self-cleaving ribozymes.

Authors:  J Tang; R R Breaker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

4.  ATP requirements and small interfering RNA structure in the RNA interference pathway.

Authors:  A Nykänen; B Haley; P D Zamore
Journal:  Cell       Date:  2001-11-02       Impact factor: 41.582

5.  Gene therapy. Safer and virus-free?

Authors:  D Ferber
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

6.  Computer modeling of three-dimensional structure of DNA-packaging RNA (pRNA) monomer, dimer, and hexamer of Phi29 DNA packaging motor.

Authors:  Stephen Hoeprich; Peixuan Guo
Journal:  J Biol Chem       Date:  2002-03-08       Impact factor: 5.157

7.  The specifics of small interfering RNA specificity.

Authors:  Andrew Dillin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-16       Impact factor: 11.205

8.  Genetic control by a metabolite binding mRNA.

Authors:  Ali Nahvi; Narasimhan Sudarsan; Margaret S Ebert; Xiang Zou; Kenneth L Brown; Ronald R Breaker
Journal:  Chem Biol       Date:  2002-09

9.  Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice.

Authors:  O Ishida; K Maruyama; K Sasaki; M Iwatsuru
Journal:  Int J Pharm       Date:  1999-11-10       Impact factor: 5.875

10.  Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.

Authors:  L Alexopoulou; A C Holt; R Medzhitov; R A Flavell
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

View more
  15 in total

Review 1.  Nanomaterial-Enabled Cancer Therapy.

Authors:  Sabina Quader; Kazunori Kataoka
Journal:  Mol Ther       Date:  2017-05-19       Impact factor: 11.454

2.  Challenges to optimizing RNA nanostructures for large scale production and controlled therapeutic properties.

Authors:  Morgan Chandler; Martin Panigaj; Lewis A Rolband; Kirill A Afonin
Journal:  Nanomedicine (Lond)       Date:  2020-05-26       Impact factor: 5.307

3.  Stealth oxime ether lipid vesicles promote delivery of functional DsiRNA in human lung cancer A549 tumor bearing mouse xenografts.

Authors:  Anu Puri; Faisal Ibrahim; André O'Reilly Beringhs; Camryn Isemann; Paul Zakrevsky; Abigail Whittenburg; Derek Hargrove; Tapan Kanai; Rebecca S Dillard; Natalia de Val; Michael H Nantz; Xiuling Lu; Bruce A Shapiro
Journal:  Nanomedicine       Date:  2022-06-04       Impact factor: 6.096

4.  The International Society of RNA Nanotechnology and Nanomedicine (ISRNN): The Present and Future of the Burgeoning Field.

Authors:  Morgan Chandler; Brittany Johnson; Emil Khisamutdinov; Marina A Dobrovolskaia; Joanna Sztuba-Solinska; Aliasger K Salem; Koen Breyne; Roger Chammas; Nils G Walter; Lydia M Contreras; Peixuan Guo; Kirill A Afonin
Journal:  ACS Nano       Date:  2021-10-22       Impact factor: 18.027

5.  Photoactivation of sulfonated polyplexes enables localized gene silencing by DsiRNA in breast cancer cells.

Authors:  Anu Puri; Mathias Viard; Paul Zakrevsky; Serena Zampino; Arabella Chen; Camryn Isemann; Sohaib Alvi; Jeff Clogston; Upendra Chitgupi; Jonathan F Lovell; Bruce A Shapiro
Journal:  Nanomedicine       Date:  2020-03-06       Impact factor: 5.307

6.  Combination of Nucleic Acid and Mesoporous Silica Nanoparticles: Optimization and Therapeutic Performance In Vitro.

Authors:  Ridhima Juneja; Hemapriyadarshini Vadarevu; Justin Halman; Mubin Tarannum; Lauren Rackley; Jacob Dobbs; Jose Marquez; Morgan Chandler; Kirill Afonin; Juan L Vivero-Escoto
Journal:  ACS Appl Mater Interfaces       Date:  2020-08-18       Impact factor: 9.229

7.  Hydrophobicity of Lipid-Conjugated siRNAs Predicts Productive Loading to Small Extracellular Vesicles.

Authors:  Annabelle Biscans; Reka A Haraszti; Dimas Echeverria; Rachael Miller; Marie-Cecile Didiot; Mehran Nikan; Loic Roux; Neil Aronin; Anastasia Khvorova
Journal:  Mol Ther       Date:  2018-04-04       Impact factor: 11.454

Review 8.  Aptamers as Modular Components of Therapeutic Nucleic Acid Nanotechnology.

Authors:  Martin Panigaj; M Brittany Johnson; Weina Ke; Jessica McMillan; Ekaterina A Goncharova; Morgan Chandler; Kirill A Afonin
Journal:  ACS Nano       Date:  2019-11-05       Impact factor: 15.881

9.  A cationic amphiphilic co-polymer as a carrier of nucleic acid nanoparticles (Nanps) for controlled gene silencing, immunostimulation, and biodistribution.

Authors:  Justin R Halman; Ki-Taek Kim; So-Jung Gwak; Richard Pace; M Brittany Johnson; Morgan R Chandler; Lauren Rackley; Mathias Viard; Ian Marriott; Jeoung Soo Lee; Kirill A Afonin
Journal:  Nanomedicine       Date:  2019-10-25       Impact factor: 5.307

Review 10.  Nucleic acid nanoparticles (NANPs) as molecular tools to direct desirable and avoid undesirable immunological effects.

Authors:  M Brittany Johnson; Morgan Chandler; Kirill A Afonin
Journal:  Adv Drug Deliv Rev       Date:  2021-04-20       Impact factor: 17.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.